Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Now Is Your Chance

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Sep 11, 2023 9:45pm

160 Views

Post# 35630588

RE:Now Is Your Chance

Mind your business man ! We've lost enough money so we have gained the right to argue event if the share price is at $100. You invested less than 5k and now you 're at 18k . Good for you man but keep in mind that is a miserable amount that does not give you the right to snob those who lost too much!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments